MediciNova Eulerpool Ziņas

MediciNova Eulerpool News

MediciNova Akciju Ziņas

MediciNova tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās MediciNova ziņas mēs apkopojam šeit.

• 24. oktobris ·

  Benzinga
  12 Health Care Stocks Moving In Thursday's Pre-Market Session
• 24. oktobris ·

  Yahoo
  MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)
• 23. oktobris ·

  TipRanks
  MediciNova announces update of Phase 2/3 MN-166 trial at NEALS meeting
• 11. oktobris ·

  Benzinga
  12 Health Care Stocks Moving In Friday's Intraday Session
• 7. oktobris ·

  Yahoo
  MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago
• 30. septembris ·

  Yahoo
  MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
• 30. septembris ·

  Yahoo
  MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS…
• 30. septembris ·

  Thefly.com
  MediciNova to support NIH-funded EAP trial to evaluate MN166 in ALS
• 10. septembris ·

  Yahoo
  MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND
• 4. septembris ·

  Yahoo
  MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting